|
|
Article: Research and Markets: This Comprehensive Mega-Mergers: Executing Change in the Pharma Industry Report is Available Now.
- Article from:
- Business Wire
- Article date:
- July 15, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/9ea490/megamergers_exec) has announced the addition of Decision Resources, Inc.'s new report "Mega-Mergers: Executing Change in the Pharma Industry" to their offering.
If consolidation is so advantageous for boosting a pharma company to a new level of productivity, why has Pfizer engaged in not just one but three mega-mergers in the past ten years: $92.3 billion for Warner-Lambert in 2000, $60 billion for Pharmacia in 2002, and $68 billion for Wyeth in 2009? And why would Roche chairman Franz B. Humer have stated: "I'm against mega-mergers and mega-acquisitions because they have a ...